Insider filing · ARTV
Fred Aslan
President and CEO
profile →
Artiva Biotherapeutics, Inc.
ARTV · Healthcare · 18 filings in 24 months
ticker →
Fred Aslan sold $422K of Artiva Biotherapeutics (ARTV)
Executed Oct 5, disclosed Oct 6, 1 day later.
Value, as filed
$422K
61,696 sh × $6.84
Executed
Oct 5
the trade date, as filed
Disclosed
Oct 6
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
FAFred Aslan (President and CEO) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Artiva Biotherapeutics, Inc. (ARTV). The largest single filing was $690K of ARTV (61,888 sh × $11.16, as filed), executed Sep 3.
The name
ARTVHealthcare · Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for pa…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Fred Aslan in ARTV
ARTVSALE
Artiva Biotherapeutics, Inc.
$260K62,178 sh × $4.18
Exec Nov 2
Filed Nov 3 · 4:04 PM ET ARTVSALE Artiva Biotherapeutics, Inc. $169K
23,463 sh × $7.20
Exec Oct 6
Filed Oct 7 · 4:02 PM ET ARTVSALE Artiva Biotherapeutics, Inc. $256K
23,429 sh × $10.92
Exec Sep 8
Filed Sep 9 · 4:02 PM ET ARTVSALE Artiva Biotherapeutics, Inc. $690K
61,888 sh × $11.16
Exec Sep 3
Filed Sep 4 · 4:02 PM ET ARTVSALE Artiva Biotherapeutics, Inc. $244K
27,116 sh × $9.01
Exec May 19
Filed May 19 · 5:30 PM ET ARTVSALE Artiva Biotherapeutics, Inc. $153K
25,500 sh × $6.00
Exec Oct 17 2025
Filed Oct 17 2025 · 5:30 PM ET